PET-based prognostic survival model after radiotherapy for head and neck cancer-Reference-Cited by-同舟云学术

PET-based prognostic survival model after radiotherapy for head and neck cancer

Published:2018-08-21 Issue:3 Volume:46 Page:638-649
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Castelli Joël^ORCID,Depeursinge A.,Devillers A.,Campillo-Gimenez B.,Dicente Y.,Prior J. O.,Chajon E.,Jegoux F.,Sire C.,Acosta O.,Gherga E.,Sun X.,De Bari B.,Bourhis J.,de Crevoisier R.

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00259-018-4134-9/fulltext.html

Reference59 articles.

1. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4. https://doi.org/10.1245/s10434-010-0985-4 .

2. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet. 2000;355:949–55.

3. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945–52. https://doi.org/10.1056/NEJMoa032641 .

4. Bourhis J, Sire C, Graff P, Gregoire V, Maingon P, Calais G, et al. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. Lancet Oncol. 2012;13:145–53. https://doi.org/10.1016/s1470-2045(11)70346-1 .

5. Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2010;11:21–8. https://doi.org/10.1016/s1470-2045(09)70311-0 .

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prognostic Significance of Tumor SUVmax Value in Pre- and Post-Chemoradiotherapy 18F-FDG PET/CT Imaging in Patients with Localized and Advanced Head and Neck Squamous Cell Carcinoma;Nigerian Journal of Clinical Practice;2024-06

2. A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ALARM” study;Cancer Medicine;2024-01-21

3. Automatic Head and Neck Tumor segmentation and outcome prediction relying on FDG-PET/CT images: Findings from the second edition of the HECKTOR challenge;Medical Image Analysis;2023-12

4. Molecular Imaging of Head and Neck Cancers;Molecular Imaging and Therapy;2023-08-17

5. A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer in $$[^{18}$$F]FDG PET/CT;European Journal of Nuclear Medicine and Molecular Imaging;2023-04-20